These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 23319256)

  • 1. Intensity-modulated radiotherapy vs. parotid-sparing 3D conformal radiotherapy. Effect on outcome and toxicity in locally advanced head and neck cancer.
    Lambrecht M; Nevens D; Nuyts S
    Strahlenther Onkol; 2013 Mar; 189(3):223-9. PubMed ID: 23319256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxicity and outcome of intensity-modulated radiotherapy versus 3-dimensional conformal radiotherapy for oropharyngeal cancer: a matched-pair analysis.
    Al-Mamgani A; Van Rooij P; Tans L; Teguh DN; Levendag PC
    Technol Cancer Res Treat; 2013 Apr; 12(2):123-30. PubMed ID: 23098281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xerostomia after radiotherapy. What matters--mean total dose or dose to each parotid gland?
    Tribius S; Sommer J; Prosch C; Bajrovic A; Muenscher A; Blessmann M; Kruell A; Petersen C; Todorovic M; Tennstedt P
    Strahlenther Onkol; 2013 Mar; 189(3):216-22. PubMed ID: 23354440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-Field Sequential Intensity-Modulated Radiotherapy for Local-Regional Advanced Head-and-Neck Squamous Cell Carcinoma.
    Refaat T; Choi M; Thomas TO; Bacchus I; Agulnik M; Pelzer HJ; Mellott AL; Rademaker AW; Liu D; Sathiaseelan V; Mittal BB
    Am J Clin Oncol; 2015 Dec; 38(6):588-94. PubMed ID: 24136140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3D-conformal-intensity modulated radiotherapy with compensators for head and neck cancer: clinical results of normal tissue sparing.
    Wendt TG; Abbasi-Senger N; Salz H; Pinquart I; Koscielny S; Przetak SM; Wiezorek T
    Radiat Oncol; 2006 Jun; 1():18. PubMed ID: 16790059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Submandibular gland-sparing radiation therapy for locally advanced oropharyngeal squamous cell carcinoma: patterns of failure and xerostomia outcomes.
    Gensheimer MF; Liao JJ; Garden AS; Laramore GE; Parvathaneni U
    Radiat Oncol; 2014 Nov; 9():255. PubMed ID: 25424729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperfractionated accelerated radiotherapy with concomitant integrated boost of 70-75 Gy in 5 weeks for advanced head and neck cancer. A phase I dose escalation study.
    Cvek J; Kubes J; Skacelikova E; Otahal B; Kominek P; Halamka M; Feltl D
    Strahlenther Onkol; 2012 Aug; 188(8):666-70. PubMed ID: 22648405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Prospective Cohort Study Analyzing Radiation-Induced Xerostomia and Quality of Life of Head and Neck Cancer Patients Treated With Intensity-Modulated Radiotherapy and 3D Conformal Radiotherapy Techniques at a Tertiary Cancer Center in Eastern India.
    Sahoo B; Padhi S; Patra AC; Mahapatra BR; Mishra T; Mishra SR; Patro KC
    Cureus; 2023 Mar; 15(3):e36442. PubMed ID: 37090370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].
    Kiprian D; Jarząbski A; Pawłowska B; Michalski W; Kawecki A
    Otolaryngol Pol; 2011 Sep; 65(5 Suppl):117-25. PubMed ID: 22000261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program.
    Vergeer MR; Doornaert PA; Rietveld DH; Leemans CR; Slotman BJ; Langendijk JA
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):1-8. PubMed ID: 19111400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recovery of Salivary Function: Contralateral Parotid-sparing Intensity-modulated Radiotherapy versus Bilateral Superficial Lobe Parotid-sparing Intensity-modulated Radiotherapy.
    Miah AB; Gulliford SL; Morden J; Newbold KL; Bhide SA; Zaidi SH; Hall E; Harrington KJ; Nutting CM
    Clin Oncol (R Coll Radiol); 2016 Sep; 28(9):e69-e76. PubMed ID: 26994893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of xerostomia incidence after three-dimensional conformal radiation therapy and contralateral superficial lobe parotid-sparing intensity-modulated radiotherapy for oropharyngeal and hypopharyngeal cancer.
    Kawamoto T; Nihei K; Nakajima Y; Kito S; Sasai K; Karasawa K
    Auris Nasus Larynx; 2018 Oct; 45(5):1073-1079. PubMed ID: 29397249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conventional 2D (2DRT) and 3D conformal radiotherapy (3DCRT) versus intensity-modulated radiotherapy (IMRT) for nasopharyngeal cancer treatment.
    Moretto F; Rampino M; Munoz F; Ruo Redda MG; Reali A; Balcet V; Badellino S; Piva C; Schena M; Airoldi M; Ostellino O; Pecorari G; Ragona R; Ricardi U
    Radiol Med; 2014 Aug; 119(8):634-41. PubMed ID: 24424659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study on the impact of patient-related parameters in the ability to spare parotid glands by intensity-modulated radiotherapy for head and neck squamous cell carcinomas.
    Bandlamudi BP; Sharan K; Yathiraj PH; Singh A; Reddy A; Fernandes DJ; Srinivasa VM
    J Cancer Res Ther; 2018; 14(6):1220-1224. PubMed ID: 30488833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of radiation techniques in the treatment of mediastinal lymphoma: from 3D conformal radiotherapy (3DCRT) to intensity-modulated RT (IMRT) using helical tomotherapy (HT): a single-centre experience and review of the literature.
    Besson N; Pernin V; Zefkili S; Kirova YM
    Br J Radiol; 2016; 89(1059):20150409. PubMed ID: 26744079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can dose reduction to one parotid gland prevent xerostomia?--A feasibility study for locally advanced head and neck cancer patients treated with intensity-modulated radiotherapy.
    Anand AK; Jain J; Negi PS; Chaudhoory AR; Sinha SN; Choudhury PS; Kumar R; Munjal RK
    Clin Oncol (R Coll Radiol); 2006 Aug; 18(6):497-504. PubMed ID: 16909975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective functional outcomes in sequential population based cohorts of stage III/ IV oropharyngeal carcinoma patients treated with 3D conformal vs. intensity modulated radiotherapy.
    Kerr P; Myers CL; Butler J; Alessa M; Lambert P; Cooke AL
    J Otolaryngol Head Neck Surg; 2015 May; 44(1):17. PubMed ID: 25964113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing the risk of xerostomia and mandibular osteoradionecrosis: the potential benefits of intensity modulated radiotherapy in advanced oral cavity carcinoma.
    Ahmed M; Hansen VN; Harrington KJ; Nutting CM
    Med Dosim; 2009; 34(3):217-24. PubMed ID: 19647632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of 3D conformal radiation therapy and intensity-modulated radiation therapy in patients with endometrial cancer: efficacy, safety and prognostic analysis.
    Ta MH; Schernberg A; Giraud P; Monnier L; Darai É; Bendifallah S; Schlienger M; Touboul E; Orthuon A; Challand T; Huguet F; Rivin Del Campo E
    Acta Oncol; 2019 Aug; 58(8):1127-1134. PubMed ID: 31017032
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.